[Survival with Distant Metastatic Disease in Head and Neck Cancer. A Retrospective Analysis]

Overview

Journal HNO

Specialty Otorhinolaryngology

Date 2007 Mar 3

PMID 17333044

Citations 2

Authors

B Dietl

J Marienhagen

C Schaefer

F Pohl

T Murthum

O Kolbl

Affiliations

Soon will be listed here.

Abstract

Questions: The objective of this retrospective analysis was to investigate parameters with a potential impact on survival in a collective of 114 patients with distant metastatic disease after head and neck cancer.

Patients And Methods: The primary endpoint was the survival with distant metastatic disease, the secondary endpoint was overall survival. Primary therapy, local recurrence, second neoplasms, palliative chemotherapy (CHT) and radiotherapy (RT), as well as Karnofsky performance status (KPS) at the time of diagnosis of the metastases were analyzed as potential impact parameters using the log-rank test with subsequent Cox regression analysis.

Results: Palliative CHT (P=0.0020) and KPS (P=0.0011) had a significant positive impact on the median survival probability with metastases (8.2 months) using the log-rank test, KPS at the time of diagnosis of metastases remained as an independent prognostic parameter in the Cox regression (P=0.0013). Primary therapy, local tumor control and KPS had a significant positive influence on the median overall survival probability (18.5 months) univariately (P=0.0139, P=0.0106, P= 0.0096) and multivariately (P=0.0123, and P=0.0063, P=0.0197, respectively).

Conclusions: KPS at the time of diagnosis of metastases is an independent prognostic parameter for both endpoints. Lacking evidence for life prolongation, palliative therapies should therefore first and foremost focus on the stabilization of the KPS.

Citing Articles

The crucial role of SEMA3F in suppressing the progression of oral squamous cell carcinoma.

Liu Y, Li R, Yin K, Ren G, Zhang Y Cell Mol Biol Lett. 2018; 22:32.

PMID: 29299034 PMC: 5745788. DOI: 10.1186/s11658-017-0064-y.

Survival of patients with head and neck cancer. Impact of physical status and comorbidities.

Sadat F, Wienke A, Dunst J, Kuhnt T Strahlenther Onkol. 2011; 188(1):62-70.

PMID: 22189439 DOI: 10.1007/s00066-011-0009-8.

References

Konski A, Feigenberg S, Chow E . Palliative radiation therapy. Semin Oncol. 2005; 32(2):156-64. DOI: 10.1053/j.seminoncol.2004.11.013. View

Pignon J, Bourhis J, Domenge C, Designe L . Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet. 2000; 355(9208):949-55. View

Wulf J, Haedinger U, Oppitz U, Thiele W, Mueller G, Flentje M . Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys. 2004; 60(1):186-96. DOI: 10.1016/j.ijrobp.2004.02.060. View

Schrijvers D, Vermorken J . Role of taxoids in head and neck cancer. Oncologist. 2000; 5(3):199-208. DOI: 10.1634/theoncologist.5-3-199. View

Baumann I, Seibolt M, Zalaman I, Dietz K, Plinkert P, Maassen M . [Quality of life in patients with oropharyngeal carcinoma. Gender influences the subjective evaluation]. HNO. 2005; 54(5):376-81. DOI: 10.1007/s00106-005-1330-2. View

Simon C, Plinkert P . [Transoral resection of locally advanced squamous cell carcinoma of the side wall of the oropharynx: multimodal treatment concepts in transition]. HNO. 2006; 54(8):589-90. DOI: 10.1007/s00106-006-1438-z. View

Uppelschoten J, Wanders S, de Jong J . Single-dose radiotherapy (6 Gy): palliation in painful bone metastases. Radiother Oncol. 1995; 36(3):198-202. DOI: 10.1016/0167-8140(95)01587-7. View

Hennemann B . [Palliative chemotherapy of head and neck cancer: present status and future development]. Laryngorhinootologie. 2006; 85(3):172-8. DOI: 10.1055/s-2005-921107. View

Forastiere A, Metch B, Schuller D, Ensley J, Hutchins L, Triozzi P . Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study. J Clin Oncol. 1992; 10(8):1245-51. DOI: 10.1200/JCO.1992.10.8.1245. View

10.

Jacobs C, Lyman G, Velez-Garcia E, Sridhar K, Knight W, Hochster H . A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J Clin Oncol. 1992; 10(2):257-63. DOI: 10.1200/JCO.1992.10.2.257. View

11.

Shah J, Lydiatt W . Treatment of cancer of the head and neck. CA Cancer J Clin. 1995; 45(6):352-68. DOI: 10.3322/canjclin.45.6.352. View

12.

Baumann I, Seibolt M, Zalaman I, Dietz K, Maassen M, Plinkert P . Quality of life in patients with oropharyngeal carcinoma after primary surgery and postoperative irradiation. J Otolaryngol. 2006; 35(5):332-7. DOI: 10.2310/7070.2006.0077. View

13.

Pinto H, Jacobs C . Chemotherapy for recurrent and metastatic head and neck cancer. Hematol Oncol Clin North Am. 1991; 5(4):667-86. View

14.

de Mulder P . The chemotherapy of head and neck cancer. Acta Otorhinolaryngol Belg. 2000; 53(3):247-52. View

15.

Shaw H . Palliation in head and neck cancer. J Laryngol Otol. 1985; 99(11):1131-42. DOI: 10.1017/s0022215100098303. View

16.

Ferlito A, Shaha A, Silver C, Rinaldo A, Mondin V . Incidence and sites of distant metastases from head and neck cancer. ORL J Otorhinolaryngol Relat Spec. 2001; 63(4):202-7. DOI: 10.1159/000055740. View

17.

Kirkbride P, Mackillop W, Priestman T, Browman G, Gospodarowicz M, Rousseau P . The role of palliative radiotherapy for bone metastases. Can J Oncol. 1996; 6 Suppl 1:33-8. View

18.

Adamo V, Ferraro G, Pergolizzi S, Sergi C, Laudani A, Settineri N . Paclitaxel and cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma. Oral Oncol. 2004; 40(5):525-31. DOI: 10.1016/j.oraloncology.2003.10.010. View

19.

Moosmann P, Egli F, Stahel R, Jost L . Weekly paclitaxel and carboplatin combination chemotherapy in patients with advanced squamous cell carcinoma of the head and neck. Onkologie. 2004; 26(6):568-72. DOI: 10.1159/000074153. View

20.

Calhoun K, Fulmer P, Weiss R, Hokanson J . Distant metastases from head and neck squamous cell carcinomas. Laryngoscope. 1994; 104(10):1199-205. DOI: 10.1288/00005537-199410000-00003. View